Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis

Monica Manhas; Retash Shan; Sheetal Kotwal; Suman K Kotwal; Mrityunjay Gupta

doi:10.5455/njppp.2023.13.06308202218082022

2025, Vol: 15, Issue: 2

15 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form

« Previous Article

Original Research
Online Published: 26 Aug 2022

Natl J Physiol Pharm Pharmacol. 2023; 13(4): 736-739

doi: 10.5455/njppp.2023.13.06308202218082022

Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis

Monica Manhas, Retash Shan, Sheetal Kotwal, Suman K Kotwal, Mrityunjay Gupta.

Abstract
Background: Chronic kidney disease (CKD) is an irreversible deterioration of renal function and cardiovascular disease is the leading cause of mortality in CKD patients.

Aims and Objectives: The aim of this study was to assess the pattern of lipid profile among cases of CKD.

Materials and Methods: A cross-sectional study was conducted for 1 year covering total 200 cases (males and females) of newly diagnosed or known cases of CKD. Parameters recorded were as follows: Fasting blood sugar, Serum urea (S. Urea), Serum Creatinine (S. Creatinine), and lipid profile. Estimated glomerular filtration rate (eGFR) was calculated by Cockcroft-Gault formula.

Results: Mean age was 51.04 years in conservative management patients and 53.20 years in hemodialysis patients. Overall, male-to-female ratio was 1.82:1. S. Creatinine, S. Urea, and eGFR were deranged more in patients on hemodialysis (Group 2). Mean values of low-density lipoprotein (LDL)-cholesterol, very low-density lipoproteins (VLDL), and serum triglycerides (TG) were significantly higher in patients on hemodialysis compared to those on conservative management, while mean high-density lipoprotein cholesterol was significantly lower. Dyslipidemia was more common in female CKD patients (P = 0.02).

Conclusion: Dyslipidemia in CKD worsened as patients progressed to severe stages with significant increase in TG, LDL, and VLDL levels in hemodialysis cases in comparison to conservatively managed, confirming presence of atherogenic lipid profile needing early intervention to prevent cardiovascular complications.

Key words: Lipid Profile; Chronic Kidney Disease; Hemodialysis

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Monica Manhas Articles by Retash Shan Articles by Sheetal Kotwal Articles by Suman K Kotwal Articles by Mrityunjay Gupta
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Manhas M, Shan R, Kotwal S, Kotwal SK, Gupta M. Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis. Natl J Physiol Pharm Pharmacol. 2023; 13(4): 736-739. doi:10.5455/njppp.2023.13.06308202218082022

Web Style

Manhas M, Shan R, Kotwal S, Kotwal SK, Gupta M. Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis. https://www.njppp.com/?mno=59661 [Access: March 08, 2025]. doi:10.5455/njppp.2023.13.06308202218082022

AMA (American Medical Association) Style

Manhas M, Shan R, Kotwal S, Kotwal SK, Gupta M. Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis. Natl J Physiol Pharm Pharmacol. 2023; 13(4): 736-739. doi:10.5455/njppp.2023.13.06308202218082022

Vancouver/ICMJE Style

Manhas M, Shan R, Kotwal S, Kotwal SK, Gupta M. Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis. Natl J Physiol Pharm Pharmacol. (2023), [cited March 08, 2025]; 13(4): 736-739. doi:10.5455/njppp.2023.13.06308202218082022

Harvard Style

Manhas, M., Shan, . R., Kotwal, . S., Kotwal, . S. K. & Gupta, . M. (2023) Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis. Natl J Physiol Pharm Pharmacol, 13 (4), 736-739. doi:10.5455/njppp.2023.13.06308202218082022

Turabian Style

Manhas, Monica, Retash Shan, Sheetal Kotwal, Suman K Kotwal, and Mrityunjay Gupta. 2023. Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis. National Journal of Physiology, Pharmacy and Pharmacology, 13 (4), 736-739. doi:10.5455/njppp.2023.13.06308202218082022

Chicago Style

Manhas, Monica, Retash Shan, Sheetal Kotwal, Suman K Kotwal, and Mrityunjay Gupta. "Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 736-739. doi:10.5455/njppp.2023.13.06308202218082022

MLA (The Modern Language Association) Style

Manhas, Monica, Retash Shan, Sheetal Kotwal, Suman K Kotwal, and Mrityunjay Gupta. "Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis." National Journal of Physiology, Pharmacy and Pharmacology 13.4 (2023), 736-739. Print. doi:10.5455/njppp.2023.13.06308202218082022

APA (American Psychological Association) Style

Manhas, M., Shan, . R., Kotwal, . S., Kotwal, . S. K. & Gupta, . M. (2023) Lipid profile of chronic kidney disease patients on two different modalities of treatment: Conservative versus hemodialysis. National Journal of Physiology, Pharmacy and Pharmacology, 13 (4), 736-739. doi:10.5455/njppp.2023.13.06308202218082022

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article